Modulation of Urate Transport by Drugs

Area of Science:

• Pharmacology
• Nephrology
• Biochemistry

Background:

• Primates exhibit exceptionally high serum urate (SU) levels compared to other mammals.
• Urate functions as an antioxidant but can cause gout and inflammation when concentrated.
• Drug interactions with urate transporters significantly influence SU levels.

Purpose of the Study:

• To evaluate if in vitro transporter interaction studies can predict in vivo effects on serum urate levels.
• To determine the role of specific urate transporters in drug-induced SU modulation.

Main Methods:

• Compiled literature data on transporter interactions of known uricosuric and hyperuricemic drugs.
• Assessed the predictive accuracy of in vitro cut-offs (e.g., Cmax/IC50) for in vivo SU changes.

Main Results:

• Interaction with the URAT1 transporter is a key determinant of a drug's net effect on SU levels.
• In vitro inhibition data, when interpreted with recommended cut-offs, accurately predicts clinical outcomes.
• URAT1 inhibition is more influential than secretory transporter interactions.

Conclusions:

• Early in vitro safety assessments for urate transport are crucial for drug development.
• Identify drug candidates with potential for significant SU imbalances.
• Monitor inhibition/trans-stimulation of reabsorptive transporters, particularly URAT1, and secretory transporters.